-- Robert Preidt
FRIDAY, Aug. 29, 2014 (HealthDay News) -- Prostate cancer
patients lacking knowledge about the disease have difficulty making
good treatment decisions. This can lead to worse quality of care
and long-term results, new research suggests.
The study included 70 men, with a median age of 63. All were
newly diagnosed with localized prostate cancer.
Poor understanding of the disease was associated with greater
difficulty deciding which treatment to choose and less confidence
that the treatment would be effective, the study found.
"For prostate cancer, there is no one right answer when it comes to treatment. It comes down to the right answer for each specific patient, and that is heavily dependent on their own personal preferences," study first author Dr. Alan Kaplan, a resident physician in the urology department at the University of California, Los Angeles, said in a university news release.
"Men in general, and specifically economically disadvantaged men, have a hard time deciding what their preferences are, how they feel about any possible complications and what the future after treatment might be like. If you don't know anything about your disease, you'll have a really tough time making a decision," Kaplan explained.
The findings, published in the Sept. 1 print issue of the
Cancer, suggest that doctors need to identify and educate
men with little knowledge about prostate cancer in order to help
them feel more comfortable making treatment decisions.
"If you get shot in the gut, there aren't many options. You go into the operating room to get fixed up," Kaplan said. "With prostate cancer, there are lots of options and not all are right for everybody."
Treatment options for prostate cancer include surgery,
radiation, and burning or freezing tumors. Or, patients might
choose active surveillance. That means they don't receive treatment
but are closely monitored for changes in their cancer.
Prostate cancer is the second most commonly diagnosed cancer in
men. This year, about 233,000 American men will be diagnosed with
prostate cancer, and nearly 30,000 will die from the disease,
according to the university news release.
The U.S. National Cancer Institute has more about
prostate cancer treatment.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.